Teva Says EpiPen Suit Only Remedy For Colo. Takings

By Daniel Ducassi · December 7, 2023, 10:03 PM EST

Teva Pharmaceuticals USA has urged a Colorado federal judge to keep alive its lawsuit challenging the state's epinephrine auto-injector affordability program as an unconstitutional taking, arguing that the alternative of repeatedly...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Motion

Case Information

Case Title

Teva Pharmaceuticals USA, Inc. v. Weiser et al

Case Number

Court

Colorado

Nature of Suit

Constitutionality of State Statutes

Date Filed

October 03, 2023

Recent Articles By Daniel

April 23, 2024
Colo. Neural Privacy Law Has Attys Scratching Their Heads
April 08, 2024
High Court Creating DEI Headwinds, Colo. AG Says
March 08, 2024
Colo. DNA Scientist Fudged Data For 650 Cases, Police Say
February 27, 2024
Anesthesia Group Settles Colo. AG's Monopoly Claims
February 21, 2024
Judges Doubt Surgery Center Co. Can Undo Contract Loss
February 09, 2024
Mental Health App Says Former Exec Can't Lead Rival
November 30, 2023
Hospital Must Pay $400K In Costs After $40M Malpractice Loss
November 22, 2023
DaVita Faces New Wage Suit Over Meal, Rest Breaks
November 21, 2023
Panel Probes 'Common Sense' In Doctor's Insemination Case
October 31, 2023
Colo. Nursing Home Exec Accused Of Siphoning Profits